Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spinal stimulation may boost lung function in paralyzed patients

NCT ID NCT03998527

Knowledge-focused Sponsor: University of Louisville Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether non-invasive spinal cord stimulation, combined with breathing, arm, or trunk training, can improve lung and breathing muscle function in people with spinal cord injuries. 36 adults with injuries at or above the T5 level are participating. The goal is to see which combination works best to help them breathe easier.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2018

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

All SCI research participants, irrespective of gender, will be selected based on the following: Inclusion Criteria: 1. At least 18 years of age at the time of enrollment; 2. Stable medical condition; 3. Non-progressive SCI T5 or above; 4. Sustained SCI at least 12 months prior to enrollment; 5. At least a 15% deficit in pulmonary function outcomes (FVC or FEV1) as was detected by screening spirometry Exclusion Criteria: 1. Untreated musculoskeletal dysfunction; 2. Unhealed fracture; 3. Untreated contracture or pressure sore; 4. Ventilator dependence; 5. Untreated depression, psychiatric disorder, or ongoing drug abuse; 6. Major pulmonary or cardiovascular disease; 7. Major esophageal or gastrointestinal disease; 8. Endocrine disorder, malignancy, marked obesity, deep vein thrombosis, or HIV/AIDS related illness; 9. Secondary causes of orthostatic hypotension (anemia, hypervolemia, endocrine, or neurological); 10. Pregnancy by self-report. All Non-Disabled research participants, irrespective of gender, will be selected based on the following: Inclusion Criteria: 1. At least 21 years of age at the time of enrollment. 2. FVC and FEV1 values 80% of predicted or above indicating healthy pulmonary function by screening spirometry. Exclusion Criteria: 1. History of respiratory disease by self-report, 2. History of cardiovascular disease by self-report.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Respiratory Aspiration spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spinal cord injuries

Contacts and locations

Locations

  • Frazier Rehabilitation and Neuroscience Institute

    Louisville, Kentucky, 40202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.